|
|
|
|
|
|
|
|
abstract
July 2016
Highlights
- •
- 18% of EOC patients in the NCDB did not receive surgical treatment.
- •
- 22% of elderly patients with advanced disease received only systemic treatment; 23% were untreated.
- •
- It is unclear how often deviation from best-practices guidelines is clinically appropriate.
Purpose
To identify prevalence, correlates and survival implications of non-surgically managed epithelial ovarian cancer (EOC).
Methods
The
National Cancer Database (NCDB) was queried for EOC cases between 2003
and 2011. Type of treatment, survival data, reasons for non-surgical
treatment, clinicopathologic and process-based factors were collected.
Logistic regression identified independent predictors of surgical
treatment; Cox proportional hazards regression modeled association
between time to death and receipt of surgery.
Results
172,687
of 210,667 patients (82%) received surgical treatment for EOC. 95% of
patients treated non-surgically had stage III, stage IV or unknown stage
disease. The reason for non-surgical treatment was unclear in 80% of
cases. Black race and uninsurance were significantly associated with
non-surgical treatment. Median survival time was 57.4 months for surgery with or without systemic treatment compared to
11.9 months for systemic treatment alone and
1.4 months for no treatment. Relative to surgical
treatment, the adjusted hazard ratio for death associated with systemic
treatment alone was 1.9. Among 29,921 patients older than 75
with Stage III/IV disease, 21.5% received only systemic treatment; 22.8%
were entirely untreated.
Conclusion
18%
of EOC patients in the NCDB did not receive surgical treatment. These
patients experienced significantly worsened survival. Prospective
investigation is needed to determine how often apparent deviation from
best-practices guidelines is clinically appropriate. Non-surgically
treated patients may be at risk for poor access to gynecologic oncology
care and deserve further study.
Keywords
- Health disparities;
- Health services research;
- Ovarian cancer;
- Health policy;
- Cancer care delivery research
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.